Since these two classes of drugs work through the same renin-angiotensin pathway and have a similar effect in cardiovascular disease and renal protection [7], physicians make a prescribing decision between ACEIs and ARBs when the patient needs a renin-angiotensin drugs. The gene discussed is REN; the disease is cardiovascular disorder.